Navigation Links
Personalized Stem Cells, Inc. Submits Investigational New Drug (IND) Application for the Treatment of Osteoarthritis with Stem Cells
Date:6/18/2019

Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, has submitted an Investigational New Drug (IND) application to the FDA for use of a person’s own adipose-derived stem cells to treat their osteoarthritis. The first clinical trial uses stem cells as a treatment of osteoarthritis in the knee. This IND is the first of several planned clinical trials which will enable qualified PSC-enrolled physicians to provide FDA compliant, regulated quality cell therapy to patients suffering from osteoarthritis. PSC plans to conduct a series of FDA-IND approved clinical trials starting with uses in orthopedics and expanding to other medical conditions in the future.

PSC has contracted with VetStem Biopharma for cGMP stem cell manufacturing for use in Phase I/II human trials by the PSC network of physicians. PSC has also licensed the VetStem patent portfolio and intellectual property for use of adipose-derived regenerative cells.

The current environment of in-office, unregulated manufacturing of stem cells by physicians has come under serious regulatory action by the FDA, FTC, and the Federation of State Medical Boards. It is clear that the only allowed use of stem cells will be through legitimate FDA clinical trials with manufacturing in a controlled FDA inspected, GMP compliant facility. Qualified physicians enrolled in the PSC network will have access to quality manufactured, safety tested cells for use in FDA approved clinical trials. They will also be able to share their experiences with other PSC network physicians in order to better define and implement the highest quality treatment options in the future.

PSC was founded by Robert Harman, DVM, MPVM and Michael Dale, both of whom also co-founded VetStem and are both experienced serial entrepreneurs.

“This is a unique opportunity in history to have a profound influence on the development and adoption of a game-changing medical technology,” says Mr. Dale. “Regenerative medicine may offer help for a wide array of conditions that are not effectively treated with today’s medicines.”

“We believe that we can jumpstart human stem cell therapy using the VetStem GMP manufacturing capabilities, extensive preclinical data, and experience. Mr. Dale will rapidly lead PSC forward with legitimate FDA approved clinical trials,” says Dr. Harman.

About Personalized Stem Cells, Inc.
Personalized Stem Cells was formed in 2018 to advance and legitimize human regenerative medicine. This privately held biopharmaceutical enterprise, based near San Diego (California), offers qualified physicians who enroll, an FDA compliant autologous stem cell product (from patient’s own fat tissue) for use in FDA approved clinical trials. PSC is driving development and adoption of stem cell and regenerative medicine within the FDA-IND process by providing quality manufactured, safety tested cells, and well-defined clinical trials. PSC has licensed a portfolio of over 70 issued patents in the field of regenerative medicine.

Read the full story at https://www.prweb.com/releases/personalized_stem_cells_inc_submits_investigational_new_drug_ind_application_for_the_treatment_of_osteoarthritis_with_stem_cells/prweb16384983.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. VetStem Biopharma, Parent Company of Personalized Stem Cells, is Approved for Stem Cell Manufacturing by the California Department of Public Health
2. A New Kind of Thinking Cap: Worcester Polytechnic Institute Researchers Are Using Brain Imaging to Improve Personalized Learning Environments
3. RSNA: Personalized Treatment Benefits Kidney Cancer Patients
4. PhysIQ Personalized Physiology Analytics (PPA) Wins DPharm Idol 2017
5. Director of Scientific Programs of NIH’s All of Us Research Program to Provide Update at the 9th Annual Personalized & Precision Medicine Conference
6. ACEA Biosciences Announces Collaboration with Memorial Sloan Kettering Cancer Center on Personalized CAR T Cell Therapy
7. ISABS: Personalized Medicine Conference With Nobel Prize Laureates Participation to be Held in Dubrovnik, Croatia
8. Notable Labs Enters into a Collaboration Agreement with IntelliCyt to Develop a Phenotypic Personalized Medicine Platform for Cancer Patients
9. Proove Health Foundation Is Created to Support the Role of Personalized Medicine in Public Health Epidemics
10. IntelliCyt and FIMM Announce a Collaboration to Advance Personalized Medicine in Cancer Treatment
11. Proove Biosciences Highlights Personalized Medicine Technology as an Approach to Reduce Prescription Drug Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/12/2019)... ... November 12, 2019 , ... ... welcomed their new Director of Forensic Genealogy, Melinde Lutz Byrne, to the organization. ... to ultimately provide investigative leads to law enforcement through proven genealogy and ...
(Date:11/6/2019)... ... 2019 , ... LeadingBiotech ,?an exclusive event series bringing ... East/West CEO conference to be held January 11-12, 2020 at the ... week of the J.P. Morgan Healthcare Conference and other biotech industry conferences, collectively ...
(Date:11/2/2019)... ... October 31, 2019 , ... ... used to communicating with each other: study managers, principal investigators, supply chain managers, ... a party is not informed of the latest data, potentially leading to patient ...
(Date:10/30/2019)... ... October 30, 2019 , ... Western University of Health ... and technology play in educating the next generation of health care providers. , ... presentations by WesternU administrators and representatives of companies working with the University on ...
Breaking Biology Technology:
(Date:11/6/2019)... ... November 06, 2019 , ... NDA Partners Chairman Carl ... executive with expertise in clinical pharmacology and pharmacometrics and a widely recognized expert ... has joined the firm as an Expert Consultant. , Dr. Stanski has served ...
(Date:11/5/2019)... ... 05, 2019 , ... Catalent, the leading global provider of ... consumer health products, today announced it will present at the upcoming World Orphan ... – 14, 2019. , On Wednesday, Nov. 13 at 3:20 p.m., Philip Wills, ...
(Date:11/2/2019)... ... November 01, 2019 , ... Stay on top of current hot topics ... Access to all webinars is free, so be sure to register today to save ... http://www.xtalks.com to see our upcoming webinars: , CLINICAL OPERATIONS , November 14 ...
Breaking Biology News(10 mins):